Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue    
Revenue $ 24,236 $ 18,397
Costs and expenses    
Selling, general and administrative 18,816 18,949
Research and development 456 216
Depreciation and amortization 11,184 9,655
Operating loss (13,253) (16,901)
(Loss) gain on derivatives (254) 1,531
Income on equity method investment 0 529
Interest income 400 435
Interest expense (2,634) (1,853)
Other income (expense), net 1 (943)
Loss before income taxes (15,740) (17,202)
Income tax expense (70) (113)
Net loss (15,810) (17,315)
Other comprehensive income 0 0
Total comprehensive loss $ (15,810) $ (17,315)
Basic:    
Net income (loss) per share of common stock (in dollars per share) $ (0.11) $ (0.14)
Diluted:    
Net income (loss) per share of common stock, diluted (in dollars per share) $ (0.11) $ (0.14)
Imagery & software analytical services    
Revenue    
Revenue $ 17,833 $ 15,760
Costs and expenses    
Costs excluding depreciation and amortization 3,445 3,699
Professional & engineering services    
Revenue    
Revenue 6,403 2,637
Costs and expenses    
Costs excluding depreciation and amortization $ 3,588 $ 2,779